普昂医疗
(920069)
| 流通市值：5.58亿 | | | 总市值：16.89亿 |
| 流通股本：1748.95万 | | | 总股本：5291.98万 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 349,532,909.33 | 223,178,034.96 | 99,307,104.37 | 382,193,622.56 |
| 营业收入 | 349,532,909.33 | 223,178,034.96 | 99,307,104.37 | 382,193,622.56 |
| 二、营业总成本 | 257,387,853.91 | 164,816,534.87 | 73,165,861.63 | 286,279,519.41 |
| 营业成本 | 165,035,468.63 | 104,396,875.77 | 45,657,809.58 | 183,325,700.62 |
| 税金及附加 | 5,425,093.28 | 3,618,008.85 | 1,613,091.55 | 7,213,468.92 |
| 销售费用 | 39,062,565.04 | 25,424,278.07 | 11,672,865.47 | 42,742,836.72 |
| 管理费用 | 27,733,925.01 | 17,438,719.37 | 7,890,040.31 | 32,106,939.03 |
| 研发费用 | 15,583,057.11 | 10,599,781.19 | 4,625,504.98 | 21,152,137.22 |
| 财务费用 | 4,547,744.84 | 3,338,871.62 | 1,706,549.74 | -261,563.1 |
| 其中:利息费用 | 93,657.7 | 93,657.7 | 62,103.64 | 502,418.99 |
| 其中:利息收入 | 328,849.59 | 202,429.6 | 69,805.78 | 272,579.62 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 146,482.46 | 39,654.9 | - | -52.38 |
| 资产处置收益 | -90,302.42 | -41,040.72 | -51,040.72 | -27,650.17 |
| 资产减值损失(新) | -777,439.04 | -995,988.48 | -582,916.65 | -2,419,735.14 |
| 信用减值损失(新) | -308,064.94 | -270,889.64 | 375,128.63 | -895,319.79 |
| 其他收益 | 5,296,320.44 | 3,358,765.83 | 1,934,101.64 | 12,280,132.72 |
| 四、营业利润 | 96,412,051.92 | 60,452,001.98 | 27,816,515.64 | 104,851,478.39 |
| 加:营业外收入 | 1,527,120.53 | 1,508,515.97 | 15,576.14 | 114,456.8 |
| 减:营业外支出 | 222,188.44 | 51,441.12 | 46,323.05 | 1,527,878.03 |
| 五、利润总额 | 97,716,984.01 | 61,909,076.83 | 27,785,768.73 | 103,438,057.16 |
| 减:所得税费用 | 13,113,662.44 | 8,769,898.45 | 4,121,548.24 | 13,662,271.54 |
| 六、净利润 | 84,603,321.57 | 53,139,178.38 | 23,664,220.49 | 89,775,785.62 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 84,603,321.57 | 53,139,178.38 | 23,664,220.49 | 89,775,785.62 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 84,603,321.57 | 53,139,178.38 | 23,664,220.49 | 89,775,785.62 |
| 扣除非经常损益后的净利润 | 82,559,492.14 | 51,456,325.86 | 23,287,991.38 | 84,502,909.58 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.71 | 1.12 | 0.56 | 2.12 |
| (二)稀释每股收益 | 1.71 | 1.12 | 0.56 | 2.12 |
| 九、综合收益总额 | 84,603,321.57 | 53,139,178.38 | 23,664,220.49 | 89,775,785.62 |
| 归属于母公司股东的综合收益总额 | 84,603,321.57 | 53,139,178.38 | 23,664,220.49 | 89,775,785.62 |
| 公告日期 | 2026-10-28 | 2026-08-26 | 2026-04-23 | 2026-02-05 |
| 审计意见(境内) | | | | 标准无保留意见 |